Diamino heterocyclic carboxamide compound

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8969336
APP PUB NO 20120040968A1
SERIAL NO

13266164

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided is a compound useful as an inhibitor against the kinase activity of EML4-ALK fusion protein.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ASTELLAS PHARMA INC5-1 NIHONBASHI-HONCHO 2 -CHOME CHUO-KU TOKYO 103-8411 ?103-8411
KOTOBUKI PHARMACEUTICAL CO LTDHANISHINA-GUN NAGANO 389-0697

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Iikubo, Kazuhiko Tokyo, JP 9 190
Iwai, Yoshinori Nagano, JP 12 210
Kamikawa, Akio Tokyo, JP 17 195
Kondoh, Yutaka Tokyo, JP 26 279
Kurosawa, Kazuo Tokyo, JP 10 243
Matsuya, Takahiro Tokyo, JP 12 171
Shimada, Itsuro Tokyo, JP 19 274
Tomiyama, Hiroshi Nagano, JP 38 811

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 3, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00